Importantly, in vivo selective deletion of STAT1 drives Mi/MΦ toward an inflammation-resolving phenotype, resulting in mitigation of neuroinflammation and improvement of long-term stroke outcomes. This evidence concerns the gene STAT1 and stroke disorder.